KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Price, Quote, News and Overview
TSX-V:KHRN - TSX Venture Exchange - CA49374L3065 - Common Stock - Currency: CAD
KHRN.CA Quote, Performance and Key Statistics
TSX-V:KHRN (5/5/2023, 7:00:00 PM)
0.04
0 (0%)
The current stock price of KHRN.CA is 0.04 CAD. In the past month the price decreased by -11.11%. In the past year, price decreased by -75%.
KHRN.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.71 | 3.26B | ||
| CRON.CA | CRONOS GROUP INC | 14.44 | 1.00B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.29 | 754.55M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 52.27 | 572.87M | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 553.79M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 355.12M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 26.06 | 327.17M | ||
| ACB.CA | AURORA CANNABIS INC | 9.68 | 313.25M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 256.72M | ||
| HITI.CA | HIGH TIDE INC | N/A | 252.03M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 30.67 | 246.34M | ||
| CRDL.CA | CARDIOL THERAPEUTICS INC-A | N/A | 159.02M |
Related stock screener links
About KHRN.CA
Company Profile
Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. The company is headquartered in Toronto, Ontario and currently employs 310 full-time employees. The company went IPO on 2012-10-25. The Company’s product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The firm provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The firm sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.
Company Info
KHIRON LIFE SCIENCES CORP
100 King St.W., Suite 1600, 1 First Canadian Place
TORONTO ONTARIO V6C 2B5 CA
CEO: Alvaro Torres
Employees: 310
Phone: 17055273564.0
KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ
What is the stock price of KHIRON LIFE SCIENCES CORP today?
The current stock price of KHRN.CA is 0.04 CAD.
What is the ticker symbol for KHIRON LIFE SCIENCES CORP stock?
The exchange symbol of KHIRON LIFE SCIENCES CORP is KHRN and it is listed on the TSX Venture Exchange exchange.
On which exchange is KHRN.CA stock listed?
KHRN.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for KHIRON LIFE SCIENCES CORP stock?
7 analysts have analysed KHRN.CA and the average price target is 0.1 CAD. This implies a price increase of 155% is expected in the next year compared to the current price of 0.04. Check the KHIRON LIFE SCIENCES CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is KHIRON LIFE SCIENCES CORP worth?
KHIRON LIFE SCIENCES CORP (KHRN.CA) has a market capitalization of 7.19M CAD. This makes KHRN.CA a Nano Cap stock.
How many employees does KHIRON LIFE SCIENCES CORP have?
KHIRON LIFE SCIENCES CORP (KHRN.CA) currently has 310 employees.
What are the support and resistance levels for KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
KHIRON LIFE SCIENCES CORP (KHRN.CA) has a resistance level at 0.04. Check the full technical report for a detailed analysis of KHRN.CA support and resistance levels.
Is KHIRON LIFE SCIENCES CORP (KHRN.CA) expected to grow?
The Revenue of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 36.43% in the next year. Check the estimates tab for more information on the KHRN.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KHRN.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KHRN.CA, evaluating the profitability, health, valuation and growth aspects
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Sales and EPS estimates to see what analysts future expectations are.
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Chart to make your own analysis
- KHIRON LIFE SCIENCES CORP (KHRN.CA) Latest news and press-releases to stay up to date.
Does KHIRON LIFE SCIENCES CORP (KHRN.CA) stock pay dividends?
KHRN.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of KHIRON LIFE SCIENCES CORP (KHRN.CA)?
KHIRON LIFE SCIENCES CORP (KHRN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).
KHRN.CA Technical Analysis
KHRN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA. Both the profitability and financial health of KHRN.CA have multiple concerns.
KHRN.CA Financial Highlights
Over the last trailing twelve months KHRN.CA reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -59.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.05 |
KHRN.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to KHRN.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 39.13% and a revenue growth 36.43% for KHRN.CA